Penn State University

psu.edu

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

260

Active

57

Phase 3

4

Total enrollment

66,013

Pipeline matrix

Showing 16 of 16 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Combined Oral Contraceptive—————2
Contraceptive Vaginal Ring—————2
simvastatin 10mg—————1
Bazedoxifene 20/Estrogens,Con 0.45Mg Tb—————1
Elagolix Oral—————1
Estradiol patch—————1
Aspirin—————1
Whole Egg—————1
Yogurt smoothie with BB-12—————1
Yogurt smoothie—————1
Low dose ASA—————1
TRPM8 Agonist—————1
TRPV1 Agonist—————1
TRPV4 Agonist—————1
TRPM8, TRPV4, TRPV1 Agonists—————1
Salsalate Pill—————1

Next readouts

  • 2022-10
  • 2025-12-31
  • 2025-12-31
  • 2025-12-31
  • 2026-07
  • 2026-08-01
  • 2026-09-01
  • 2027-02-27
  • 2028-12

Top conditions

  • Cardiovascular Disease20
  • Eating Behavior15
  • Cardiovascular Diseases12
  • Obesity12
  • Pediatric Obesity10
  • Feeding Behavior9
  • Metabolic Syndrome7
  • Anxiety6

Frequently asked questions about Penn State University

How many clinical trials does Penn State University have on ClinicalTrials.gov?
Penn State University is listed as the lead sponsor on 260 clinical trials in ClinicalTrials.gov, 57 of which are currently active (recruiting, enrolling, or ongoing).
How many of Penn State University's trials are in Phase 3?
4 of Penn State University's trials are in Phase 3, spread across 16 active drug programs.
What therapeutic areas does Penn State University focus on?
Penn State University's most-studied conditions on ClinicalTrials.gov are Cardiovascular Disease, Eating Behavior, Cardiovascular Diseases, Obesity, Pediatric Obesity.
When are Penn State University's next clinical trial readouts?
Penn State University has 9 upcoming primary-completion readouts tracked here; the soonest is “Probiotics and Gut Health”, expected around 2022-10.